These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 5245322)

  • 101. The acute management of intrathecal methotrexate overdose: pharmacologic rationale and guidelines.
    Addiego JE; Ridgway D; Bleyer WA
    J Pediatr; 1981 May; 98(5):825-8. PubMed ID: 6971923
    [No Abstract]   [Full Text] [Related]  

  • 102. Seizures associated with vincristine sulfate therapy.
    Johnson FL; Bernstein ID; Hartmann JR; Chard RL
    J Pediatr; 1973 Apr; 82(4):699-702. PubMed ID: 4512319
    [No Abstract]   [Full Text] [Related]  

  • 103. Re: High-dose compared with intermediate-dose methotrexate in children with a first relapse of acute lymphatic leukemia.
    Cohen IJ
    Blood; 2008 Aug; 112(3):910. PubMed ID: 18650464
    [No Abstract]   [Full Text] [Related]  

  • 104. Complications of chemotherapy.
    Cairncross JG; Pexman W; Farrell M
    Can J Neurol Sci; 1985 May; 12(2):149-53. PubMed ID: 3860276
    [No Abstract]   [Full Text] [Related]  

  • 105. Intermediate dose methotrexate and recurrent pleural effusions.
    Van Hoof A; Tricot G; Verwilghen RL
    Acta Clin Belg; 1983; 38(6):388-90. PubMed ID: 6585110
    [No Abstract]   [Full Text] [Related]  

  • 106. Intractable diarrhoea associated with continuation of cytotoxic chemotherapy during acute infective enteritis.
    Pinkerton CR; Glasgow JF; Dempsey SI
    Eur J Pediatr; 1983 Mar; 140(1):68-70. PubMed ID: 6575914
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Intermittent high dose corticosteroid treatment in childhood cancer: behavioral and emotional consequences.
    Harris JC; Carel CA; Rosenberg LA; Joshi P; Leventhal BG
    J Am Acad Child Psychiatry; 1986 Jan; 25(1):120-4. PubMed ID: 3456385
    [No Abstract]   [Full Text] [Related]  

  • 108. Methotrexate toxicity: correlation with duration of administration, plasma levels, dose and excretion pattern.
    Goldie JH; Price LA; Harrap KR
    Eur J Cancer (1965); 1972 Aug; 8(4):409-14. PubMed ID: 5073303
    [No Abstract]   [Full Text] [Related]  

  • 109. Methotrexate in asthma--an alternative view.
    Cash JM
    J Allergy Clin Immunol; 1993 Jan; 91(1 Pt 1):140. PubMed ID: 8423269
    [No Abstract]   [Full Text] [Related]  

  • 110. [Clinico-pharmacologic, cytochemical and Feulgen photometric studies in adult undifferentiated cell leukemias under combination chemotherapy with vincristine, daunorubicine and prednisone].
    Obrecht P; Merker H; Hennekeuser HH; Meuret G; Westerhausen M; Simon A
    Klin Wochenschr; 1970 Nov; 48(21):1281-91. PubMed ID: 4103871
    [No Abstract]   [Full Text] [Related]  

  • 111. Anti-folate resistance in leukemia: treatment with "high-dose" methotrexate and citrovorum factor.
    Bender RA
    Cancer Treat Rev; 1975 Sep; 2(3):215-24. PubMed ID: 1104164
    [No Abstract]   [Full Text] [Related]  

  • 112. Induction of remission in acute leukemia with prednisone and intravenous methotrexate.
    Brubaker CA; Gilchrist GS; Hammond D; Hyman CB; Shore NA; Williams KO
    J Pediatr; 1968 Oct; 73(4):623-5. PubMed ID: 5245322
    [No Abstract]   [Full Text] [Related]  

  • 113. Induction of remission in acute leukemia of childhood by combination of prednisone and either 6-mercaptopurine or methotrexate.
    Krivit W; Brubaker C; Hartmann J; Murphy ML; Pierce M; Thatcher G
    J Pediatr; 1966 Jun; 68(6):965-8. PubMed ID: 5935078
    [No Abstract]   [Full Text] [Related]  

  • 114. Induction of remission in childhood leukemia with vincristine and 6-mercaptopurine and methotrexate. Administration in sequence after prednisone.
    Sitarz AL; Brubaker C; Hartman J; Leiken S; Murphy ML; Wolff JA; Perrin E
    Cancer; 1968 May; 21(5):920-5. PubMed ID: 5239542
    [No Abstract]   [Full Text] [Related]  

  • 115. Varying prednisone dosage in remission induction of previously untreated childhood leukemia.
    Leikin SL; Brubaker C; Hartmann JR; Murphy ML; Wolff JA; Perrin E
    Cancer; 1968 Mar; 21(3):346-51. PubMed ID: 5237296
    [No Abstract]   [Full Text] [Related]  

  • 116. New treatment schedule with improved survival in childhood leukemia. Intermittent parenteral vs daily oral administration of methotrexate for maintenance of induced remission. Acute leukemia group B.
    JAMA; 1965 Oct; 194(1):75-81. PubMed ID: 5896942
    [No Abstract]   [Full Text] [Related]  

  • 117.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 118.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 119.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.